The pharma industry is being disrupted in multiple ways. Data has never been more accessible and the speed at which it is flowing has left the industry reeling. Fundamental to the success of these advances is the need to integrate data from diverse sources and leverage predictive analytics to drive informed, real-time decisions. This article explores how pharma can maximize the value of different data types to advance research.READ MORE
"In our latest experiment, we have reversed the ageing of human cells, which could provide the basis for future anti-degeneration drugs."READ MORE
With more and more applications of the microfluidics industry becoming apparent, giving scientists the tools they need has never been more important. This article highlights major industries that benefit from microfluidic technology, and provides insights into how demands for microfluidic components are changing.READ MORE
The Biosimilars Market is Likely to Grow at a Compound Annual Growth Rate of 49.1% from 2015 to 2020Article
The global biosimilars market was valued at $2,552.0 million in 2014 and is expected to reach $26,551.3 million by 2020, supported by a compound annual growth rate (CAGR) of 49.1% during the forecast period 2015 to 2020, according to Allied Market Research’s report.READ MORE
Chromatography is the backbone of analytical laboratories with high performance liquid chromatography (HPLC) representing the largest portion. Classical HPLC has been challenged - or complemented - in the last decade by ultrahigh performance liquid chromatography (UHPLC).
Cancer is a complex genetic disease that is caused by specific changes to the genes in one cell or group of cells. These changes disrupt normal cell function – specifically affecting how a cell grows and divides. This article outlines some of the key differences between cancer cells and normal cells.READ MORE
Nearly half of adults with autism will experience clinical depression in their lifetime, according to new research.READ MORE